08:49     JILIN CHANGLONG<08049> - Quarterly Results Announcement (1)         

    Jilin Province Huinan Changlong Bio-pharmacy Company Limited announced on 
    10/05/2005:                                                               
    (stock code: 08049 )                                                      
                                                                              
    Year end date                         :31/12/2005                         
    Currency                              :RMB                                
    Auditors' report                      :N/A                                
    1st Quarterly Report Reviewed by      :Audit Committee                    
                                                                              
    Important Note :                                                          
                                                                              
    This result announcement form only contains extracted information from    
    and should be read in conjunction with the detailed results announcement  
    of the issuer, which can be viewed on the GEM website at                  
    http://www.hkgem.com                                                      
                                                                              
                                              ( Unaudited)      ( Unaudited)  
                                                  Current Last Corresponding  
                                                   Period            Period   
                                           from 01/01/2005   from 01/01/2004  
                                             to 31/03/2005     to 31/03/2004  
                                                     $'000             $'000  
                                                                              
    Turnover                              :         15,921            15,957  
    Profit/(Loss) from Operations         :          2,705             3,179  
    Finance cost                          :          (113)              (25)  
    Share of Profit/(Loss) of Associates  :            N/A               N/A  
    Share of Profit/(Loss) of Jointly                                         
             Controlled Entites           :            N/A               N/A  
    Profit/(Loss) after Taxation & MI     :          1,742             2,113  
    % Change Over the Last Period         :         -17.56%                   
    EPS / (LPS)                                                               
              Basic (in dollar)           :     RMB 0.0031        RMB 0.0038  
              Diluted (in dollar)         :            N/A               N/A  
    Extraordinary (ETD) Gain/(Loss)       :            N/A               N/A  
    Profit (Loss) after ETD Items         :         1,742             2,113   
    1st Quarter Dividends per Share       :            NIL               NIL  
    (specify if with other options)       :            N/A               N/A  
    B/C Dates for 1st Quarter Dividends   :            N/A                    
    Payable Date                          :            N/A                    
    B/C Dates for (-) General Meeting     :            N/A                    
    Other Distribution for Current Period :            NIL                    
    B/C Dates for Other Distribution      :            N/A                    
                                           (bdi: both days inclusive)         
                                                                              
    For and on behalf of                                                      
     Jilin Province Huinan Changlong Bio-pharmacy Company Limited             
                                                                              
    Signature :                                                               
    Name      : Zhang Hong                                                    
    Title     : Chairman                                                      
                                                                              
    Responsibility statement                                                  
                                                                              
    The directors of the Company (the "Directors") as at the date hereof      
    hereby collectively and individually accept full responsibility for the   
    accuracy of the information contained in this results announcement form   
    (the "Information") and confirm, having made all reasonable inquiries,    
    that to the best of their knowledge and belief the Information are        
    accurate and complete in all material respects and not misleading and     
    that there are no other matters the omission of which would make the      
    Information herein inaccurate or misleading.The Directors acknowledge     
    that the Stock Exchange has no responsibility whatsoever with regard to   
    the Information and undertake to indemnify the Exchange against all       
    liability incurred and all losses suffered by the Exchange in connection  
    with or relating to the Information.                                      
                                                                              
    Remarks:                                                                  
                                                                              
    1. Basis of Preparation                                                   
                                                                              
    The Company was established as a state-owned enterprise in the            
    People's Republic of China (the "PRC") in 1989. On 29 December 1995,      
    under the relevant provisions of the PRC Company Law, the Company         
    was re-organized from a state-owned enterprise to a limited               
    liability company. Further on 16 August 1996, with the approval           
    of the Economic Restructuring Commission of Jilin Province, the           
    Company was then converted into a joint stock limited company.            
    The Company's H shares were listed on the Growth Enterprise Market        
    of The Stock Exchange of Hong Kong Limited on 24 May 2001.                
                                                                              
    The unaudited consolidated results have been prepared in accordance with  
    all applicable accounting standards issued by the Hong Kong Institute of  
    Certified Public Accountants ("HKICPA") and accounting principles         
    generally accepted in Hong Kong.                                          
                                                                              
    In 2004, the HKICPA issued a number of new and revised Hong Kong          
    Financial Reporting Standards and Hong Kong Accounting Standards          
    ("new HKFRSs") which are effective for accounting periods                 
    beginning on or after 1 January 2005.  The adoption of the new            
    HKFRSs had no material impact on the Group's results of operations        
    and financial position.